3QQU

Cocrystal structure of unphosphorylated igf with pyrimidine 8

Summary for 3QQU

• Entry DOI: 10.2210/pdb3qqu/pdb
• Descriptor: Insulin-like growth factor 1 receptor, N~2~-[3-methoxy-4-(morpholin-4-yl)phenyl]-N~4~-(quinolin-3-yl)pyrimidine-2,4-diamine (3 entities in total)
• Functional Keywords: igf, kinase, inhibitor, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• Biological source: Homo sapiens (human)
• Cellular location: Membrane; Single-pass type I membrane protein: P08069
• Total number of polymer chains: 4
• Total formula weight: 139107.60

Authors

Huang, X. (deposition date: 2011-02-16, release date: 2011-04-20, Last modification date: 2024-02-21)

Primary citation

Buchanan, J.L.,Newcomb, J.R.,Carney, D.P.,Chaffee, S.C.,Chai, L.,Cupples, R.,Epstein, L.F.,Gallant, P.,Gu, Y.,Harmange, J.C.,Hodge, K.,Houk, B.E.,Huang, X.,Jona, J.,Joseph, S.,Jun, H.T.,Kumar, R.,Li, C.,Lu, J.,Menges, T.,Morrison, M.J.,Novak, P.M.,van der Plas, S.,Radinsky, R.,Rose, P.E.,Sawant, S.,Sun, J.R.,Surapaneni, S.,Turci, S.M.,Xu, K.,Yanez, E.,Zhao, H.,Zhu, X.
Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors.
Bioorg.Med.Chem.Lett., 21:2394-2399, 2011

PubMed Abstract: The insulin-like growth factor-1 receptor (IGF-1R) plays an important role in the regulation of cell growth and differentiation, and in protection from apoptosis. IGF-1R has been shown to be an appealing target for the treatment of human cancer. Herein, we report the synthesis, structure-activity relationships (SAR), X-ray cocrystal structure and in vivo tumor study results for a series of 2,4-bis-arylamino-1,3-pyrimidines.

PubMed: 21414779
DOI: 10.1016/j.bmcl.2011.02.075

Experimental method

X-RAY DIFFRACTION (2.9 Å)